Selfemra

Premature Ejaculation, Cataplexy, Bulimia Nervosa + 11 more
Treatment
6 FDA approvals
20 Active Studies for Selfemra

What is Selfemra

FluoxetineThe Generic name of this drug
Treatment SummaryFluoxetine is an antidepressant medication approved by the FDA in 1987. It belongs to a class of drugs called selective serotonin reuptake inhibitors (SSRIs) and is primarily used to treat depression. However, it can also be prescribed for other mental health conditions.
Prozacis the brand name
image of different drug pills on a surface
Selfemra Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Prozac
Fluoxetine
1987
490

Approved as Treatment by the FDA

Fluoxetine, also known as Prozac, is approved by the FDA for 6 uses such as Bipolar 1 Disorder and Major depressive disorder, recurrent episode .
Bipolar 1 Disorder
Used to treat Bipolar 1 Disorder in combination with Olanzapine
Major depressive disorder, recurrent episode
Used to treat Major depressive disorder, recurrent episode in combination with Olanzapine
Premenstrual Dysphoric Disorder (PMDD)
Bipolar Disorder
Used to treat Bipolar 1 Disorder in combination with Olanzapine
Depression
Used to treat Depression in combination with Olanzapine
Unipolar Depression
Used to treat Major depressive disorder, recurrent episode in combination with Olanzapine

Effectiveness

How Selfemra Affects PatientsFluoxetine works by blocking the serotonin transporter in the brain, which helps to maintain higher levels of serotonin. It has a low attraction to other receptors in the brain, which is why it is considered to have fewer side effects than other antidepressant drugs.
How Selfemra works in the bodyFluoxetine is a drug used to treat depression. It works by increasing the amount of serotonin, a chemical messenger in the brain, which helps improve mood. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) which means it stops the brain from taking in extra serotonin. It has a strong effect on serotonin, but only a weak effect on other neurotransmitters like noradrenaline and dopamine. It also interacts with the 5-HT2C receptor, which helps increase the levels of noradrenaline and dopamine in the brain.

When to interrupt dosage

The proposed measure of Selfemra is contingent upon the recognized condition, for instance Myoclonus, Bipolar Disorder and Unipolar Depression. The dosage is contingent upon the technique of delivery (e.g. Tablet, coated or Oral) listed in the table below.
Condition
Dosage
Administration
Premature Ejaculation
, 90.0 mg, 40.0 mg, 20.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 60.0 mg, 20.0 mg/mL, 15.0 mg
, Capsule, delayed release, Capsule, delayed release - Oral, Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Solution, Solution - Oral, Liquid, Liquid - Oral, Tablet, coated, Tablet, coated - Oral
Cataplexy
, 90.0 mg, 40.0 mg, 20.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 60.0 mg, 20.0 mg/mL, 15.0 mg
, Capsule, delayed release, Capsule, delayed release - Oral, Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Solution, Solution - Oral, Liquid, Liquid - Oral, Tablet, coated, Tablet, coated - Oral
Bulimia Nervosa
, 90.0 mg, 40.0 mg, 20.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 60.0 mg, 20.0 mg/mL, 15.0 mg
, Capsule, delayed release, Capsule, delayed release - Oral, Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Solution, Solution - Oral, Liquid, Liquid - Oral, Tablet, coated, Tablet, coated - Oral
Anorexia Nervosa
, 90.0 mg, 40.0 mg, 20.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 60.0 mg, 20.0 mg/mL, 15.0 mg
, Capsule, delayed release, Capsule, delayed release - Oral, Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Solution, Solution - Oral, Liquid, Liquid - Oral, Tablet, coated, Tablet, coated - Oral
Panic Disorder
, 90.0 mg, 40.0 mg, 20.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 60.0 mg, 20.0 mg/mL, 15.0 mg
, Capsule, delayed release, Capsule, delayed release - Oral, Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Solution, Solution - Oral, Liquid, Liquid - Oral, Tablet, coated, Tablet, coated - Oral
Alcoholism
, 90.0 mg, 40.0 mg, 20.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 60.0 mg, 20.0 mg/mL, 15.0 mg
, Capsule, delayed release, Capsule, delayed release - Oral, Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Solution, Solution - Oral, Liquid, Liquid - Oral, Tablet, coated, Tablet, coated - Oral
Unipolar Depression
, 90.0 mg, 40.0 mg, 20.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 60.0 mg, 20.0 mg/mL, 15.0 mg
, Capsule, delayed release, Capsule, delayed release - Oral, Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Solution, Solution - Oral, Liquid, Liquid - Oral, Tablet, coated, Tablet, coated - Oral
moderate to severe symptoms
, 90.0 mg, 40.0 mg, 20.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 60.0 mg, 20.0 mg/mL, 15.0 mg
, Capsule, delayed release, Capsule, delayed release - Oral, Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Solution, Solution - Oral, Liquid, Liquid - Oral, Tablet, coated, Tablet, coated - Oral
Depression
, 90.0 mg, 40.0 mg, 20.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 60.0 mg, 20.0 mg/mL, 15.0 mg
, Capsule, delayed release, Capsule, delayed release - Oral, Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Solution, Solution - Oral, Liquid, Liquid - Oral, Tablet, coated, Tablet, coated - Oral
Myoclonus
, 90.0 mg, 40.0 mg, 20.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 60.0 mg, 20.0 mg/mL, 15.0 mg
, Capsule, delayed release, Capsule, delayed release - Oral, Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Solution, Solution - Oral, Liquid, Liquid - Oral, Tablet, coated, Tablet, coated - Oral
Bipolar Disorder
, 90.0 mg, 40.0 mg, 20.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 60.0 mg, 20.0 mg/mL, 15.0 mg
, Capsule, delayed release, Capsule, delayed release - Oral, Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Solution, Solution - Oral, Liquid, Liquid - Oral, Tablet, coated, Tablet, coated - Oral
maintenance therapy
, 90.0 mg, 40.0 mg, 20.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 60.0 mg, 20.0 mg/mL, 15.0 mg
, Capsule, delayed release, Capsule, delayed release - Oral, Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Solution, Solution - Oral, Liquid, Liquid - Oral, Tablet, coated, Tablet, coated - Oral
Obsessive-Compulsive Disorder
, 90.0 mg, 40.0 mg, 20.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 60.0 mg, 20.0 mg/mL, 15.0 mg
, Capsule, delayed release, Capsule, delayed release - Oral, Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Solution, Solution - Oral, Liquid, Liquid - Oral, Tablet, coated, Tablet, coated - Oral
Depression
, 90.0 mg, 40.0 mg, 20.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 60.0 mg, 20.0 mg/mL, 15.0 mg
, Capsule, delayed release, Capsule, delayed release - Oral, Oral, Capsule, Capsule - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Kit, Solution, Solution - Oral, Liquid, Liquid - Oral, Tablet, coated, Tablet, coated - Oral

Warnings

Selfemra Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Selfemra.
Common Selfemra Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be decreased when combined with Fluoxetine.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Fluoxetine.
Alectinib
Major
The metabolism of Alectinib can be decreased when combined with Fluoxetine.
Aminophylline
Major
The metabolism of Aminophylline can be decreased when combined with Fluoxetine.
Axitinib
Major
The metabolism of Axitinib can be decreased when combined with Fluoxetine.
Selfemra Toxicity & Overdose RiskIn a report of 234 fluoxetine overdoses, the most common side effects were drowsiness, shaking, rapid heartbeat, nausea, and vomiting. Most of the time, aggressive supportive care is all that is needed to reverse the effects. However, more severe reactions can occur when taking large doses of fluoxetine or when combined with other drugs. These reactions can include seizures, symptoms similar to serotonin syndrome, and muscle breakdown.

Selfemra Novel Uses: Which Conditions Have a Clinical Trial Featuring Selfemra?

Currently, 881 active trials are examining the potential of Selfemra to manage Disease, Anorexia Nervosa and assist in maintenance therapy.
Condition
Clinical Trials
Trial Phases
Unipolar Depression
51 Actively Recruiting
Not Applicable, Phase 4, Early Phase 1, Phase 3, Phase 2, Phase 1
Depression
194 Actively Recruiting
Phase 2, Not Applicable, Phase 4, Phase 1, Early Phase 1, Phase 3
Bulimia Nervosa
0 Actively Recruiting
Alcoholism
6 Actively Recruiting
Not Applicable, Phase 2, Phase 3
Anorexia Nervosa
0 Actively Recruiting
moderate to severe symptoms
0 Actively Recruiting
Bipolar Disorder
0 Actively Recruiting
Depression
337 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 4, Phase 3
Panic Disorder
0 Actively Recruiting
maintenance therapy
0 Actively Recruiting
Obsessive-Compulsive Disorder
16 Actively Recruiting
Not Applicable, Phase 3, Phase 2, Early Phase 1, Phase 1
Myoclonus
1 Actively Recruiting
Not Applicable
Cataplexy
0 Actively Recruiting
Premature Ejaculation
0 Actively Recruiting

Selfemra Reviews: What are patients saying about Selfemra?

4.7Patient Review
3/20/2009
Selfemra for Depression
I was experiencing depression and struggling to find solutions to our financial problems. This medication has helped me to cope better and see the bright side of things. I am also a caregiver for an elderly parent with Alzheimer's disease.
4.3Patient Review
2/13/2009
Selfemra for "Change of Life" Signs
This drug has really helped me to better regulate my mood swings. In less than a month, I started seeing real results that have stuck around.
2.3Patient Review
11/19/2008
Selfemra for Premenstrual Disorder with a State of Unhappiness
I've been on this medication for over a year and I constantly feel like I have the flu. No improvement whatsoever. The only brand that doesn't give me any side effects is Sarafem, but it's much more expensive.
2Patient Review
12/30/2008
Selfemra for "Change of Life" Signs
I was taking Sarafem, but it became too expensive so I switched to this generic brand. Unfortunately, I just feel tired all the time now.

Patient Q&A Section about selfemra

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How long does fluoxetine last?

"This means that after stopping the prescription, it will take four to six days for the drug to lose half of its effectiveness."

Answered by AI

What does antidepressants do?

"The chemicals known as neurotransmitters are increased in activity by antidepressant medications. This increased activity appears to help reduce symptoms related to depression and anxiety."

Answered by AI

What is Sarafem used for?

"Sarafem is a prescription medication used to treat symptoms associated with major depressive disorder, obsessive-compulsive disorder, bulimia nervosa, panic disorder, and premenstrual dysphoric disorder. Sarafem may be used as a standalone treatment or in conjunction with other medications. Sarafem falls under a class of drugs known as antidepressants and SSRIs."

Answered by AI

Can you drink while taking fluoxetine?

"You can drink alcohol while taking fluoxetine, but it may make you feel sleepy. It might be best to stop drinking alcohol for the first few days of treatment until you see how the medicine affects you."

Answered by AI

Clinical Trials for Selfemra

Have you considered Selfemra clinical trials? We made a collection of clinical trials featuring Selfemra, we think they might fit your search criteria.
Have you considered Selfemra clinical trials? We made a collection of clinical trials featuring Selfemra, we think they might fit your search criteria.
Have you considered Selfemra clinical trials? We made a collection of clinical trials featuring Selfemra, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top